• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

139
19
13
13
11

COUNTRY

5
4
4
4
3

PRICE

6
93
122
487

PUBLISHED

1
45
117
487

PRODUCT TYPE

479
5
2
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE

Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis

Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis....

November 2012
FROM

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis. The...

November 2012
FROM

PharmaPoint: Rheumatoid Arthritis - United Kingdom Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - United Kingdom Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis...

November 2012
FROM

Remicade (Rheumatoid Arthritis) Forecast and Market Analysis

The RA market is currently very dynamic, with the November 6, 2012 FDA approval of Pfizer's Xeljanz (tofacitinib) and novel oral therapies awaiting approval such as: Eli Lilly's anti-BAFF, tabalumab...

November 2012
FROM

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis....

November 2012
FROM

PharmaPoint: Rheumatoid Arthritis - Italy Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Italy Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - Italy Drug...

November 2012
FROM

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fostamatinib (Rheumatoid Arthritis) Forecast and Market...

November 2012
FROM

PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis -...

November 2012
FROM
Olive Allergy - Pipeline Review, H2 2012 Olive Allergy - Pipeline Review, H2 2012 - Product Thumbnail Image

Olive Allergy - Pipeline Review, H2 2012

Olive Allergy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Olive Allergy - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

November 2012
FROM
Axial Spondyloarthritis - Pipeline Review, H2 2012 Axial Spondyloarthritis - Pipeline Review, H2 2012 - Product Thumbnail Image

Axial Spondyloarthritis - Pipeline Review, H2 2012

Axial Spondyloarthritis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Axial Spondyloarthritis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

November 2012
FROM
Grass Pollen Allergy - Pipeline Review, H2 2012 Grass Pollen Allergy - Pipeline Review, H2 2012 - Product Thumbnail Image

Grass Pollen Allergy - Pipeline Review, H2 2012

Grass Pollen Allergy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Grass Pollen Allergy - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

November 2012
FROM
Heart Transplantation - Pipeline Review, H2 2012 Heart Transplantation - Pipeline Review, H2 2012 - Product Thumbnail Image

Heart Transplantation - Pipeline Review, H2 2012

Heart Transplantation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Heart Transplantation - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

November 2012
FROM
Myasthenia Gravis - Pipeline Review, H2 2012 Myasthenia Gravis - Pipeline Review, H2 2012 - Product Thumbnail Image

Myasthenia Gravis - Pipeline Review, H2 2012

Myasthenia Gravis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Myasthenia Gravis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

November 2012
FROM
Hereditary Angioedema (HAE) - Pipeline Review, H2 2012 Hereditary Angioedema (HAE) - Pipeline Review, H2 2012 - Product Thumbnail Image

Hereditary Angioedema (HAE) - Pipeline Review, H2 2012

Hereditary Angioedema (HAE) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Hereditary Angioedema (HAE) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

November 2012
FROM
Auto Inflammatory Disease - Pipeline Review, H2 2012 Auto Inflammatory Disease - Pipeline Review, H2 2012 - Product Thumbnail Image

Auto Inflammatory Disease - Pipeline Review, H2 2012

Auto Inflammatory Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Auto Inflammatory Disease - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

November 2012
FROM
Pemphigus - Pipeline Review, H2 2012 Pemphigus - Pipeline Review, H2 2012 - Product Thumbnail Image

Pemphigus - Pipeline Review, H2 2012

Pemphigus – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Pemphigus - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information...

November 2012
FROM
Birch Pollen Allergy - Pipeline Review, H2 2012 Birch Pollen Allergy - Pipeline Review, H2 2012 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Review, H2 2012

Birch Pollen Allergy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Birch Pollen Allergy - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

November 2012
FROM
Sjogren's Syndrome - Pipeline Review, H2 2012 Sjogren's Syndrome - Pipeline Review, H2 2012 - Product Thumbnail Image

Sjogren's Syndrome - Pipeline Review, H2 2012

Sjogren's Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Sjogren's Syndrome - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

November 2012
FROM
Kawasaki Disease - Pipeline Review, H2 2012 Kawasaki Disease - Pipeline Review, H2 2012 - Product Thumbnail Image

Kawasaki Disease - Pipeline Review, H2 2012

Kawasaki Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Kawasaki Disease - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

November 2012
FROM
Sarcoidosis - Pipeline Review, H2 2012 Sarcoidosis - Pipeline Review, H2 2012 - Product Thumbnail Image

Sarcoidosis - Pipeline Review, H2 2012

Sarcoidosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Sarcoidosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

November 2012
FROM
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare